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Plastic-embedded circulating Sezary cells were ex-
amined in semithin and thin sections (assisted by the 
nuclear contour index-NCI) . Eight cases of Sezary syn-
drome were analyzed as well as 11 controls (3 cases of 
widespread eczemas and 8 cases of erythroderma), 7 
cases of mycosis fungoides, and 3 healthy individuals. 
Discriminating criteria between Sezary syndrome and 
benign diseases were sought: in addition to Sezary cells 
(NCI > 6.5) intermediate lymphocytes (5.0 < NCI ~ 6.5) 
proved to be helpful. Cases with Sezary syndrome were 
clearly differentiated when the following 3 ultrastruc-
tural criteria were fulfilled: (1) Sezary cells (SC) > 9%; 
(2) intermediate lymphocytes (IL) > 20%; (3) the sum of 
SC and IL > 37%. 
A good correlation between thin and semithin sections 
was obtained (correlation coefficient for Sezary cells r 
= 0.82). Usually the values of SC were slightly higher 
on thin sections. The diagnosis of SS can be made on 
semithin sections when the ultrastructural criteria are 
fulfilled. In this way 8 of 12 samples of Sezary syndrome 
were correctly classified. Therefore, semithin sections 
(studied by light microscopy) are recommended as a 
routine method in the diagnosis of cases suspected of 
Sezary syndrome, whereas thin sections (studied by 
electron microscopy) appeared to be necessary in prob-
lem cases only. 
In addition to erythroderma and lymphadenopathy, an in-
creased percentage of circulating Sezary cells is a prerequisite 
for the diagnosis of Sezary syndrome (SS). Sezary cells (SC) 
are atypical lymphocytes usually with T-cell membrane prop-
erties [1- 8], ultrastructurally characterized by cerebriform nu-
clei [9,10]. They are found not only in the blood of patients 
with SS, but a lso occasionally in mycosis fungoides [6,11- 15], 
in a variety of benign diseases, mainly erythrodermas of atopic 
dermatitis, contact dermatitis and psoriasis [15,16], and even 
in healthy individuals [15,17- 19]. 
However, the results of quantitative analyses of these cells 
are not always consistent with each other.· This may be due to 
4 different methods used for the determination of these cells: 
(1) blood smears (Pappenheim or Wright-Giemsa stain); (2) 
semi thin sections of plastic-embedded mononuclear blood cells 
(analyzed by light microscopy (LM); (3) thin sections of plastic-
embedded mononuclear blood cells (analyzed by electron mi-
croscopy (EM); (4) thin sections assisted by morphometric 
analyses ("nuclear contour index"- NCI) [17,20] . 
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Myrie, Zucker-Franklin, and Ramsey [21] found blood 
smears to be unreliable, whereas semithin and thin sections of 
plastic-embedded lymphoid cells were more conclusive. Even 
better results appear possible through application of morphom-
etry and particularly through the determination of the NCI 
[15,17,20] . 
The clinical significance of quantification of circulating SC 
consists in the possible early diagnosis of SS and its differen -
tiation from other benign erythrodermas. In addition "Sezary-
cytemia" appears to be a prognostically unfavorable sign in 
mycosis fungoides [15,21] . 
However, little is known as to the reliability of SC as a 
discriminating factor between SS and benign diseases and 
which methods are necessary for routine purposes. We will 
describe our own investigations using the most sensitive 
method (thin sections assisted by morphometric analyses) to 
determine circulating SC in SS and benign diseases and to 
examine their discriminating power. Furthermore, we studied 
the question of whether thin sections are a lways necessary to 
the diagnosis of SS. It will be shown that semi thin sections are 
usually, but not a lways, sufficient. 
MATERIALS AND METHODS 
The examinations were carried out in 8 cases of SS in 12 samples [4 
samples, each 3 inonths apart, in 1 patient (FGI- FG-IV), and 2 samples 
in another (LK-1, LK-II)], 7 cases of mycosis fungoides (in different 
stages), 10 cases of benign skin diseases (7 cases of erythroderma, 3 
cases with widespread eczema), 1 case of angioimmunoblastic lymph-
adenopathy (with erythroderma), and 3 healthy individuals. The clas-
sification of patients with SS is found in Table I. 
Cell Preparation 
Circulating mononuclear cells were isolated from some heparinized 
blood by Ficoll -Isopaque (d = 1.007 g/ml) centrifugation for 20 min 
and 500 g. After fixation in 1.5% glutaraldehyde and 1% osmium 
tetroxide they were embedded in Epon 812. Semithin sections were 
stai ned with methylene blue azur II and thin sections poststained with 
uranyl acetate and lead citrate. 
Evaluation of Thin S ections 
In each sample at least 100, usually 150, lymphoid cells were photo-
graphed (magnification x 4025) in a Zeiss EM 9 electron microscope. 
The nuclear area and circumference were determined semiautomati-
cally (Kontron MOP AM 03); from these data the NCI of each cell was 
calculated. The NCI is the ratio of nuclear circumference to the square 
root of the nuclear area [ 17 ,20]. The minimum value for the N CI will 
be reached by a circle: area = r2 1r; circumference = 2 r 1r; NCI = 
2r1r 2 1r ;; N; = ,;; = 2 1T ::::: 3.54. 
Lymphoid cells with a NCI > 6.5 were defined as SC (Fig 1) [15]. 
The remaining lymphoid cells were further differentiated into 2 groups: 
first, normal lymphocytes (NL) (Fig 2) with a NCI ,;;; 5.0 (normally 
found in healthy individuals-see Table II) and, second, intermediate 
lymphocytes (IL) (Fig 3) with a 5.0 < NCI .;; 6.5. From each sample a 
histogram of the NCI values was established (in Fig 4 typical histograms 
of a case of SS and of a benign erythroderma are shown) and the 
percentages of the 3 types of lymphoid cells were determined. These 
results, along with the absolute counts of peripheral lymphocytes, 
a llowed us to calculate the absolute SC counts per mm3• Furthermore, 
in each sample the highest NCI was recorded and the 25th and 70th 
percentiles of the NCI distribution were determined. 
Oct. 1983 
TABLE I. Clinical data and staging of the patients with Sezary 
syndrome and benign skin diseases at the time of blood cell 
investigation 
Patients 
(initials) Sex 
Sezary syndrome 
GS F 
GH M 
GK M 
LK-Ib F 
LK-II 
FG-Jb M 
FG-II 
FG-III 
FG-IV 
BM F 
JS F 
LL F 
age 
69 IV 
79 Ill 
66 IV 
60 III 
III 
73 III 
III 
III 
III 
73 II 
77 III 
78 IV 
B enign eczemas and erythrodermas 
staging• / Diagnosis 
FB M 62 Parapsoriasis en plaques 
WJ M 75 Parapsoriasis en p laques 
CB F 23 Nummular eczema 
OR F 57 Contact dermatit is (erythroderma) 
GG M 37 Sebostatic eczema (erythroderma) 
EO M 39 Atopic dermatitis (erythroderma) 
HD M 64 Contact dermatitis (erythroderma) 
EB M 75 Contact dermatitis (erythroderma) 
RW M 36 Nummula r eczema (e rythroderma) 
FH M 49 Pseudo "Sezary syndrome" (erythro-
derma) 
ME F 50 Angioimmunoblastic lymphadenopathy 
(erythroderma) 
• Stage I = Sezary syndrome (SS) limited to t he skin; stage II = SS 
with lymphadenopathy (clinically enla rged lymph nodes); stage III = 
SS with specific lymph node involvement; stage IV = SS with visce ral 
involvement. 
b Sequent ial analyses in intervals of 3 months. 
FIG 1. Sinary cell characterized by its cerebriform nucleus (NCI = 
11.2) Thin section, x 12,600. 
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FIG 2. Normal lymphocyte characterized by a nucleus with a smooth 
outline (NCI = 4.0). Thin section, x 12,600. 
F IG 3. Intermediate lymphocyte, characterized by a moderately in· 
dented nucleus (NCI = 5.9). Thin section, x 12,600. 
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FIG 4. Histograms of 2 typical cases: contact dermatitis with ery-
throderma (a) and Sezary syndrome (b) . A higher number of IL and 
SC is noted in b, whereas the highest values of the NCI do not appear 
to be a discriminating criterion. 
Evaluation of Semith1:n S ections 
Since the NCI is not applicable to semithin sections, criteria had to 
be determined allowing LM classification of lymphoid cells with regard 
to their degree of nuclear indentations. The following correlations 
between the NCI and nuclear indentations on EM were found on a 
pilot study: 
1. SC (NCI > 6.5) : nuclei with several indentations, the sum of 
which measures at least 1.5 of the largest diameter. 
2. NL (NCI ,;;; 5.0): nuclei with few indentations, the sum of which 
measures at most 0.5 of the largest diameter,. 
3. IL (5.0 < NCI .,; 6.5): all others. 
Using these morphologic criteria SC, IL, and NL could also be 
determined in semithin sections (Fig 5). In each sample at least 300 
lymphoid cells were analyzed. Monocytes were differentiated by means 
of their low nuclear/cytoplasma ratio and by their blunt nuclear inden-
tations. Ultrastructurally the presence of numerous dense bodies allows 
a more secure recognition. 
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RESULTS 
The percentages of the IL and SC obtained through the 
analyses of semithin and thin sections are shown in Table II. 
The absolute SC counts per mm3 and the highest NCI of each 
sample are also given. The percentages of SC among all lymph-
oid cells (absolute SC counts in parentheses) obtained through 
NCI-assisted thin section observations ranged from 12.1- 57.8% 
(500- 3900/mm3 ) in cases of SS, 0.8- 28.5% (10- 1200/mma) in 
cases of mycosis fungoides, 1- 13.4% (30- 300/mm:') in benign 
skin diseases, 3.2 % (1000/mm3 ) in a case of angioimmunoblas-
tic lymphadenopathy, and only "" 1.2% in healthy individuals. 
Taking into account the variations of SC counts, and the lack 
of a clear-cut interval between benign and malignant cases, an 
additional criterion, the percentages of IL, was evaluated. Fig 
6 depicts a scatter diagram showing the percentages of SC and 
IL: a differentiation of SS from benign cases including the 
angioimmunoblastic lymphadenopathy was possible when the 
following 3 criteria were fulfilled: 
1. sc > 9%; 
2. IL > 20% 
3. The sum of SC and IL > 37% 
Benign eczemas and erythrodermas could also be differen-
tiated from the cases of SS by means of absolute SC counts. 
None of the benign cases (with the exception of the angioim-
munoblastic lymphadenopathy) reached more than 300 SC/ 
mm\ whereas all cases with SS had SC counts higher than 500 
SC/mm3. The highest NCI was not found to be a good discrim-
inating factor, because a NCI ;;;. 11.5 was found in only 7 out 
of 12 samples of SS but also in 3 of 10 benign cases. 
The 70th percentile (25th percentile in parentheses) ranged 
FIG 5, Semithin section showing normal peripheral lymphocytes 
(NL), intermediate lymphocytes (IL), and Sezary cells (Sc). x 1700. 
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TABLE II. Percentages of Sezary cells (SC) and ,:ntermediate lymphocytes (!L) among the ly mphoid cells obtained in semithin and thin section.s. 
The percentage of normal lymphocytes= 100%- IL- SC 
Patients (initials) 
Percentage IL Percentage SC SC/mm' Highest NCI value 
EM" LM• EM LM 
Sezary syndrome 
GS 36 34 12.1 
GH 42.5 37 21.9 
GK 27.5 22 13 
LK-I ' 33.2 26 18.8 
LK-II 28.1 25 19.8 
FG-1 ' 25 22 26.8 
FG-II 24.2 21 23.3 
FG-III 26 27 38.6 
FG-IV 23.2 28 19.6 
BM 34.2 32 31.7 
JS 25 34 57.8 
LL 36.8 26 27.7 
Range 23.2-42.5 12.1-57.8 
Mycosis fungoides 
HW 7.6 17 0.8 
JZ 10.6 11 3.8 
GP 15.2 10 8.9 
FU 12.9 21 28.5 
JE 19.7 25 5.7 
AG 13.7 20 1.6 
FP 29.8 26 17.7 
Range 7.6- 29.8 10.8-28.5 
B enign eczemas and erythrodermas 
FB 22 16 11.5 
WJ 6 15 1 
CB 11.5 12 4.2 
RW 8.7 6 1.7 
OR 14 13 13.4 
HD 24 24 1.9 
EB 20.5 9 7.4 
GG 14.7 11 4.7 
FH 21.7 19 8.8 
EO 26 21 8.3 
ME 43 .9 42 3.2 
Range 6- 43.9 1- 13.4 
H ealthy individuals 
FR 2.7 8 0.9 
cs 8.5 6 1.2 
ws 12.7 8 1.2 
Range 2.7- 12.7 0.9-1.2 
• EM: results obtained in thin sections by electron microscopy. 
• LM: results obtained in semithin sections by light microscopy. 
' Sequential analyses in intervals of 3 months. 
d n.t. = not tested. 
from 5.5-8.2 (3.9-5.4) in cases of SS, 4.2-5.2 (3.7- 4.1) in benign 
skin diseases, 5.5 (4.1) in the angioimmunoblastic lymphade-
nopathy, and 4.0-4.4 (3.7-3.8) in healthy individuals. With the 
exception of the case of angioimmunoblastic lymphadenopathy 
all benign eczemas and erythrodermas could also be differen-
tiated from the cases of SS by the means of the 70th percentile. 
The correlation coefficients between thin and semithin sec-
tions were found to be: for normal lymphocytes r = 0.89, for 
intermediate lymphocytes r = 0.86, and for Sezary cells r = 
0.82 (Fig 7); this indicates a relatively high correlation between 
LM and EM findings . Even though good correlations between 
semithin and thin sections were obtained, the values of SC 
counts were usually equal to or lower on semithin sections 
compared with thin sections (in only 8 samples higher values 
with a maximum difference of 3.2% were seen). By and large, 
the same holds true for the IL. 
DISCUSSION 
Elevated circulating SC are, in addition to erythroderma, the 
dominant criterion in the diagnosis of SS. The results of studies 
of SC in cases of SS and benign diseases published in the 
10 2100 9.8 
13 800 9.9 
11 600 9 
8 3900 12 
9 3000 9.4 
21 700 11.7 
25 500 12.1 
12 600 12.9 
10 600 12.2 
12.5 2900 11 
27 2500 12.5 
10 1700 12.6 
500- 3900 9- 12.9 
4 20 6.6 
1 70 7.5 
3 200 8.7 
6 1200 13 
5 n.t.d 8 
4 10 7.8 
11 400 13.3 
10- 1200 6.6-13.3 
2 300 12.9 
2 30 7.5 
2.5 n.t. 9 
1 50 6.9 
7 200 13 
3 60 9.3 
3 100 10.5 
2 200 10.8 
5 300 9 
10 300 12.4 
6 1000 8.8 
30- 1000 6.9- 13 
1 n.t. 7.5 
1 n.t. 7.5 
1 n. t. 7.5 
literature are given in Table III (only studies using semithin 
and thin sections were considered). The lowermost percentage 
of SC still compatible with the diagnosis of SS is not well 
known. This constituted the first object in t he present study. 
For this reason the 8 cases of SS seen in our institution during 
the past 10 years were analyzed. The second aim of this study 
regards the distinction between SS and other benign erythro-
dermas. Since in benign diseases higher values of SC can be 
seen than in some cases of SS (as shown in Table III), we were 
interested in whether or not a distinction is possible through 
the analyses of the degree of nuclear indentations in circulating 
lymphoid cells. The third purpose of this study was a compar-
ison of semithin and thin sections to determine whether LM 
alone might be sufficient in the diagnosis of SS. Semithin 
sections were described earlier as a simple and useful diagnostic 
method for cutaneous lesions [24] and blood cells [21] in T-cell 
lymphomas. Usually lower counts of circulating SC were seen 
in our cases compared to findings in the literature (Table III) . 
This may be due to a generally earlier stage of the disease. 
Duncan and Winkelmann [16] found 1000 SC/mm3 to be 
necessary for establishing the diagnosis of SS; however, these 
results were obtained in blood smears. Other authors [25,26] 
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indicated 10% peripheral SC to be the lower limit in SS. In 
contrast, we observed cases with only 500 SC/mm3 and with 
less than 10% SC among the white blood cells. 
A good dist inction between SS and benign diseases was 
possible when, in addition to SC, levels of IL were considered. 
The following 3 ultrastructural criteria were fulfilled in all 12 
samples of SS, but in none of the benign cases: (1) SC > 9%; 
(2) IL > 20%; (3) the sum of SC and IL > 37%. 
As to the comparison of semithin and thin sections, the 
former were found to be sufficient in this study. However, this 
needs to be differentiated: usually the percentages of SC were 
lower in semithin sections compared to thin sections. This may 
be due to narrow nuclear indentations not showing in semithin 
sections and to difficulties in distinguishing monocytes and SC. 
Since the SC values can be higher on thin sections, SS can be 
excluded only through EM. In contrast, this diagnosis can be 
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FIG 6. Scatter diagram showing percentages of Sezary cells and 
intermediate lymphocytes determined by electron microscopy (e = 
Sezary syndrome, 0 = benign skin disease, • = mycosis fungoides, + = 
healthy individual). A distinction can be made between cases of Sezary 
syndrome and benign skin diseases by means of 3 criteria: (1) SC >9% 
(- - - ), (2) IL >20% (- - - ), (3) the sum of SC and IL >37% 
(-). 
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established through LM when the ultrastructural criteria are 
fulfilled; an ultrastructural investigation then becomes unnec-
essary, because the following ultrastructural investigation 
would usually yield equal or higher values. Applying this pro-
cedure in our study, 8 out of 12 samples were correctly classified 
on semithin sections. In the remaining 4 samples, EM would 
have been necessary. 
Determining the absolute SC counts proved to be not nec-
essary in this study, since the results using percentages of SC 
and IL among the lymphoid cells were equally sufficient. 
Myrie et al [21], comparing levels of SC in semithin and thin 
sections, found an even better correlation (r = 0.98 in 34 cases). 
The prior elimination of monocytes may have been a cause. 
However, they did not study cases with benign erythroderma 
nor did they use morphometry (NCI) . 
Vander Loo et al [15) found a NCI ~ 11.5 to be specific for 
circulating SC in cases of mycosis fungoides . We found higher 
values even in 3 of 10 benign cases, but these were rare findings. 
In another study Van der Loo et al [27] also used the 25th and 
70th percentiles as discriminating factors between cutaneous 
lesions of benign eczemas and T -cell lymphoma and proved 
their ability in undiagnosed cases of suspected cutaneous T-
cell lymphoma. However in this study the use of the 25th and 
70th percentiles did not improve the results. Furth· rmore, the 
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TABLE III. Circulating S ezary cells (SC) in Sezary syndrome (SS) and benign diseases reported in the literature (only studies using semithin or 
thin sections are listed) 
Reference Method" Diagnosis No. of cases SC/mm3 %SC/L" 
[6] (1974) EM ss 8 60-23,000 2-72 
[22] (1975) EM ss 5 7,500- 118,000 78-90 
[21 ] (1980) EM ss 8 n .t.< 9- 95 
[17] (1974) NCI ss 2 n.t. -40- 70 
[23] (1979) SD Actinic reticuloid 1 860 30 
[15] (1981) NCI Atopic dermatitis (ery- 1 225 15 
throderma) 
[15] (1981) NCI Psoriasis (erythroderma) 2 90- 100 10- 16 
[19] (1981) SD Healthy donors 4 n .t. 4 
[19] (1981) NCI Healthy donors 4 n .t . 6-7 
[18] (1977) EM Healthy donors 6 n.t. 3.2-13.3 
[18] (1977) EM Human cord blood 5 n.t. 3.8-9.6 
[17] (1974) NCI Healthy donors 1 n .t. -2 
[15] (1981) NCI Healthy donors 5 n.t. 2- 8 
"Method: SD, investigations with light microscopy on semithin sections; EM, investigations with electron microscopy on thin sections; NCI, 
nuclear contour index-assisted analyses of thin sections. 
b %SC/L = percentage of Sezary cells among all lymphoid blood cells. 
c n .t. = not tested. 
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N CI cannot be determined on semithin sections and t herefore 
percentiles cannot be calculated. 
Summarizing t he results, we recommend the use of semi th in 
sections in the determinat ion of circulating SC in cases sus-
pected to have SS. Furthermore, this technique const itutes a 
staging procedure in mycosis fungoides as more than 20% SC 
were found to be an adverse prognostic sign. Thin sections are 
necessary for borderline cases only, when higher values of SC 
cannot be excluded by LM. 
The skillful technical assistance of Ms. V. Kuegler is gratefully 
ac knowledged. 
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